Major cardiovascular events and associated factors among routine hemodialysis patients with end-stage renal disease at tertiary care hospital in Somalia

被引:6
作者
Mohamud, Mohamed Farah Yusuf [1 ]
Nur Adan, Faduma [1 ]
Jeele, Mohamed Osman Omar [1 ]
Ahmed, Mohamed A. M. [2 ]
机构
[1] Mogadishu Somali Turkish Training & Res Hosp, Mogadishu, Somalia
[2] Mogadishu Univ, Dept Pediat, Mogadishu, Somalia
关键词
hemodialysis; end-stage renal disease; cardiovascular disease; heart failure; diabetic; hypertension; CHRONIC KIDNEY-DISEASE; COMPLICATIONS; PREDICTOR;
D O I
10.3389/fmed.2023.1086359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiovascular complications are the most significant cause of death in patients undergoing routine hemodialysi (HD) with end-stage renal disease (ESRD). The main objective of this study is to determine the significant cardiac events and risk factors in patients undergoing routine hemodialysis in Somalia. MethodsWe carried out a cross-sectional retrospective study in a single dialysis center in Somalia. Two hundred out of 224 were included. All of them had ESRD and were on hemodialysis during the study period between May and October 2021. The records of all patients were reviewed, and the following parameters were analyzed socio-demographic factors, risk factors for cardiovascular disease, and the presence of cardiovascular diseases. ResultsThe mean age was 54 +/- 17.5 years (range 18-88 years), and 106 (53%) patients were males. The prevalence of a cardiovascular disease among hemodialysis patients was 29.5%. Moreover, the distribution of cardiovascular diseases was different; heart failure was the most common, about 27.1%, followed by coronary artery disease (17%), pericarditis and pericardial-effusion (13.6%), dysrhythmia (10.2%), cerebrovascular-accident (8.5%), and peripheral vascular disease (3.4%). About 176 (88%) participants had at least one modifiable cardiovascular risk factor. The most common modifiable cardiovascular risk factor was hypertension (n = 45, 25.1%), followed by anemia (n = 28, 15.6%) and diabetes (n = 26, 14.5%). Younger (18-30) participants were six times less likely to have cardiovascular events among hemodialysis than older age 0.4 (0.11-1.12). ConclusionLow prevalence rate of cardiovascular complications was confirmed in ESRD patients receiving hemodialysis in the main HD center in Somalia. Diabetes, anemia, and hypertension were the highest significant risk factors for CVD in HD patients with ESRD in Somalia.
引用
收藏
页数:7
相关论文
共 50 条
[41]   Uncovering Candidate Genes Associated with Cardiovascular Disease in Patients with Arteriovenous Fistula and End-Stage Renal Disease [J].
Zhang, Guoxin ;
Fu, Jieqiong ;
Nie, Limin .
CARDIORENAL MEDICINE, 2025, 15 (01) :386-398
[42]   Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study [J].
Bejan-Angoulvant, Theodora ;
Bergerot, Cyrille ;
Juillard, Laurent ;
Mezergues, Aline ;
Morelon, Emmanuel ;
Pouteil-Noble, Claire ;
Andre-Fouet, Xavier ;
Angoulvant, Denis .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) :2886-2891
[43]   Effects of spironolactone on cardiovascular outcomes in chronic kidney disease and end-stage renal disease patients [J].
Sun, Li-Jing ;
Xu, Bo ;
Chen, Shun-Jie ;
Liu, Shuang ;
He, Bin ;
Jiang, Geng-Ru .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02) :794-803
[44]   Comparison of the risk of de novo cardiovascular disease between hemodialysis and peritoneal dialysis in patients with end-stage renal disease [J].
Wang, I-Kuan ;
Lu, Chi-Yu ;
Lin, Cheng-Li ;
Liang, Chih-Chia ;
Yen, Tzung-Hai ;
Liu, Yao-Lung ;
Sung, Fung-Chang .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 218 :219-224
[45]   Cost of Hemodialysis Treatment and Associated Factors Among End-Stage Renal Disease Patients at the Tertiary Hospitals of Addis Ababa City and Amhara Region, Ethiopia [J].
Kassa, Daniel Asrat ;
Mekonnen, Solomon ;
Kebede, Adane ;
Haile, Tsegaye Gebremedhin .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 :399-409
[46]   Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis [J].
Malik, Jan ;
Lachmanova, Jana ;
Kudlicka, Jaroslav ;
Rocinova, Katarina ;
Valerianova, Anna ;
Bartkova, Magdalena ;
Tesar, Vladimir .
NEPHRON, 2016, 133 (03) :169-174
[47]   Early effects of hemodialysis on pulmonary function in patients with end-stage renal disease [J].
Youssef, Shaimaa M. A. ;
Okab, Ali A. ;
Mahmoud, Azza M. ;
Mohammed, Etemad A. E. .
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2025, 74 (01) :69-76
[48]   Tissue ischemia worsens during hemodialysis in end-stage renal disease patients [J].
Malik, Jan ;
Kudlicka, Jaroslav ;
Lachmanova, Jana ;
Valerianova, Anna ;
Rocinova, Katarina ;
Bartkova, Magdalena ;
Tesar, Vladimir .
JOURNAL OF VASCULAR ACCESS, 2017, 18 (01) :47-51
[49]   Mineralocorticoid Receptor Antagonists in Patients With End-Stage Renal Disease on Chronic Hemodialysis [J].
Pitt, Bertram ;
Rossignol, Patrick .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) :537-538
[50]   Hemodialysis Therapy Adherence and Contributing Factors among End-Stage Renal Disease Patients at Muhimbili National Hospital, Dar es Salaam, Tanzania [J].
Mohamedi, Salumu ;
Mosha, Idda Hubert .
KIDNEY AND DIALYSIS, 2022, 2 (01) :123-130